Astera Labs, Inc. $ALAB Holdings Trimmed by Oak Grove Capital LLC

Oak Grove Capital LLC reduced its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 12.8% during the third quarter, Holdings Channel reports. The firm owned 34,040 shares of the company’s stock after selling 5,010 shares during the quarter. Oak Grove Capital LLC’s holdings in Astera Labs were worth $12,117,000 at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. Keating Financial Advisory Services Inc. bought a new position in Astera Labs in the second quarter worth about $25,000. Archer Investment Corp bought a new stake in Astera Labs during the 2nd quarter valued at approximately $30,000. Transamerica Financial Advisors LLC bought a new stake in Astera Labs during the 2nd quarter valued at approximately $35,000. Continuum Advisory LLC bought a new stake in Astera Labs during the 2nd quarter valued at approximately $37,000. Finally, GK Wealth Management LLC purchased a new position in shares of Astera Labs during the 3rd quarter worth approximately $29,000. 60.47% of the stock is currently owned by institutional investors.

Insider Transactions at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This represents a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is currently owned by insiders.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced Aries 7, described as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers, positioning the company to benefit from expanding AI infrastructure and higher-speed data-center connectivity. Astera Labs Announces Aries 7
• Positive Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business reinforced investor optimism about the broader AI-connectivity market and helped highlight Astera’s growth opportunity. However, the companies discussed in the coverage remain dependent on major customers. Marvell AI Connectivity Market Forecast
• Neutral Sentiment: Analysts and market coverage are comparing Astera’s role in connecting AI racks with Micron’s memory and system exposure. Astera offers substantial growth potential, but competition from Marvell and Credo is intensifying. Micron Versus Astera Labs
• Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” adding pressure to the shares and signaling that the current valuation may already reflect substantial AI-related growth. Northland Securities Downgrade
• Negative Sentiment: Jim Cramer praised Astera’s business but criticized its price, reinforcing concerns that the stock’s valuation leaves limited room for execution mistakes or slower growth. Jim Cramer Discusses Astera Labs Valuation

Analysts Set New Price Targets

Several brokerages have recently issued reports on ALAB. Jefferies Financial Group increased their target price on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Barclays upped their price target on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Weiss Ratings upgraded Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a report on Thursday. Roth Capital reissued a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Bank of America boosted their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Eleven analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Astera Labs Price Performance

ALAB opened at $342.21 on Friday. The firm has a market cap of $59.37 billion, a PE ratio of 169.41 and a beta of 3.68. The stock has a 50-day moving average price of $317.44 and a 200-day moving average price of $290.39. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 2.70 EPS for the current year.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.